OEM News

Life Spine’s SImpact SI Joint OK’ed for Posterior-Oblique Approach

Enables physicians to offer the appropriate approach to suit the patient’s anatomy and pathology.

Life Spine has achieved U.S. Food and Drug Administration (FDA) clearance for its SImpact SI joint fixation system for posterior-oblique approaches.
 
SImpact allows the same instrumentation and screws to be used in both direct lateral or newly-cleared posterior-oblique approaches. This means physicians can choose the appropriate approach to suit the patient’s anatomy and pathology.
 
“SImpact offers a complete solution for SI joint fixation. This additional clearance furthers our SI portfolio by expanding the capabilities of the system to be utilized in a Posterior-Oblique approach,” Mariusz Knap, Life Spine’s senior VP of marketing told the press. “The system offers a variety of configurations including 8mm Lag screw, 12mm SImpact screw and a 14.5mm Revision screw making it one of the most robust SI systems on the market.”
 
SImpact also features a self-drilling and self-harvesting screw design as well as an anti-rotational sleeve to prevent screw back-out.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters